Cargando…

Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer

PURPOSE: To assess the feasibility of automated stereotactic volumetric modulated arc therapy (SBRT‐VMAT) planning using a simultaneous integrated boost (SIB) approach as a dose escalation strategy for SBRT in pancreatic cancer. METHODS: Twelve patients with pancreatic cancer were retrospectively re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cilla, Savino, Ianiro, Anna, Romano, Carmela, Deodato, Francesco, Macchia, Gabriella, Viola, Pietro, Buwenge, Milly, Cammelli, Silvia, Pierro, Antonio, Valentini, Vincenzo, Morganti, Alessio G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700933/
https://www.ncbi.nlm.nih.gov/pubmed/33063456
http://dx.doi.org/10.1002/acm2.13025
_version_ 1783616386731343872
author Cilla, Savino
Ianiro, Anna
Romano, Carmela
Deodato, Francesco
Macchia, Gabriella
Viola, Pietro
Buwenge, Milly
Cammelli, Silvia
Pierro, Antonio
Valentini, Vincenzo
Morganti, Alessio G.
author_facet Cilla, Savino
Ianiro, Anna
Romano, Carmela
Deodato, Francesco
Macchia, Gabriella
Viola, Pietro
Buwenge, Milly
Cammelli, Silvia
Pierro, Antonio
Valentini, Vincenzo
Morganti, Alessio G.
author_sort Cilla, Savino
collection PubMed
description PURPOSE: To assess the feasibility of automated stereotactic volumetric modulated arc therapy (SBRT‐VMAT) planning using a simultaneous integrated boost (SIB) approach as a dose escalation strategy for SBRT in pancreatic cancer. METHODS: Twelve patients with pancreatic cancer were retrospectively replanned. Dose prescription was 30 Gy to the planning target volume (PTV) and was escalated up to 50 Gy to the boost target volume (BTV) using a SIB technique in 5 fractions. All plans were generated by Pinnacle(3) Autoplanning using 6MV dual‐arc VMAT technique for flattened (FF) and flattening filter‐free beams (FFF). An overlap volume (OLV) between the PRV duodenum and the PTV was defined to correlate with the ability to boost the BTV. Dosimetric metrics for BTV and PTV coverage, maximal doses for serial OARs, integral dose, conformation numbers, and dose contrast indexes were used to analyze the dosimetric results. Dose accuracy was validated using the PTW Octavius‐4D phantom together with the 1500 2D‐array. Differences between FF and FFF plans were quantified using the Wilcoxon matched‐pair signed rank. RESULTS: Full prescription doses to the 95% of PTV and BTV can be delivered to patients with no OLV. BTV mean dose was >90% of the prescribed doses for all patients at all dose levels. Compared to FF plans, FFF plans showed significant reduced integral doses, larger number of MUs, and reduced beam‐on‐times up to 51% for the highest dose level. Despite plan complexity, pre‐treatment verification reported a gamma pass‐rate greater than the acceptance threshold of 95% for all FF and FFF plans for 3%‐2 mm criteria. CONCLUSIONS: The SIB‐SBRT strategy with Autoplanning was dosimetrically feasible. Ablative doses up to 50 Gy in 5 fractions can be delivered to the BTV for almost all patients respecting all the normal tissue constraints. A prospective clinical trial based on SBRT strategy using SIB‐VMAT technique with FFF beams seems to be justified.
format Online
Article
Text
id pubmed-7700933
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77009332020-12-03 Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer Cilla, Savino Ianiro, Anna Romano, Carmela Deodato, Francesco Macchia, Gabriella Viola, Pietro Buwenge, Milly Cammelli, Silvia Pierro, Antonio Valentini, Vincenzo Morganti, Alessio G. J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To assess the feasibility of automated stereotactic volumetric modulated arc therapy (SBRT‐VMAT) planning using a simultaneous integrated boost (SIB) approach as a dose escalation strategy for SBRT in pancreatic cancer. METHODS: Twelve patients with pancreatic cancer were retrospectively replanned. Dose prescription was 30 Gy to the planning target volume (PTV) and was escalated up to 50 Gy to the boost target volume (BTV) using a SIB technique in 5 fractions. All plans were generated by Pinnacle(3) Autoplanning using 6MV dual‐arc VMAT technique for flattened (FF) and flattening filter‐free beams (FFF). An overlap volume (OLV) between the PRV duodenum and the PTV was defined to correlate with the ability to boost the BTV. Dosimetric metrics for BTV and PTV coverage, maximal doses for serial OARs, integral dose, conformation numbers, and dose contrast indexes were used to analyze the dosimetric results. Dose accuracy was validated using the PTW Octavius‐4D phantom together with the 1500 2D‐array. Differences between FF and FFF plans were quantified using the Wilcoxon matched‐pair signed rank. RESULTS: Full prescription doses to the 95% of PTV and BTV can be delivered to patients with no OLV. BTV mean dose was >90% of the prescribed doses for all patients at all dose levels. Compared to FF plans, FFF plans showed significant reduced integral doses, larger number of MUs, and reduced beam‐on‐times up to 51% for the highest dose level. Despite plan complexity, pre‐treatment verification reported a gamma pass‐rate greater than the acceptance threshold of 95% for all FF and FFF plans for 3%‐2 mm criteria. CONCLUSIONS: The SIB‐SBRT strategy with Autoplanning was dosimetrically feasible. Ablative doses up to 50 Gy in 5 fractions can be delivered to the BTV for almost all patients respecting all the normal tissue constraints. A prospective clinical trial based on SBRT strategy using SIB‐VMAT technique with FFF beams seems to be justified. John Wiley and Sons Inc. 2020-10-16 /pmc/articles/PMC7700933/ /pubmed/33063456 http://dx.doi.org/10.1002/acm2.13025 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Cilla, Savino
Ianiro, Anna
Romano, Carmela
Deodato, Francesco
Macchia, Gabriella
Viola, Pietro
Buwenge, Milly
Cammelli, Silvia
Pierro, Antonio
Valentini, Vincenzo
Morganti, Alessio G.
Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
title Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
title_full Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
title_fullStr Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
title_full_unstemmed Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
title_short Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
title_sort automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700933/
https://www.ncbi.nlm.nih.gov/pubmed/33063456
http://dx.doi.org/10.1002/acm2.13025
work_keys_str_mv AT cillasavino automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT ianiroanna automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT romanocarmela automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT deodatofrancesco automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT macchiagabriella automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT violapietro automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT buwengemilly automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT cammellisilvia automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT pierroantonio automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT valentinivincenzo automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer
AT morgantialessiog automatedtreatmentplanningasadoseescalationstrategyforstereotacticradiationtherapyinpancreaticcancer